These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 34286397)
1. Omega 3 fatty acids effect on the vascular calcification biomarkers fetuin A and osteoprotegerin in hemodialysis patients. Werida RH; Abou-Madawy S; Abdelsalam M; Helmy MW Clin Exp Med; 2022 May; 22(2):301-310. PubMed ID: 34286397 [TBL] [Abstract][Full Text] [Related]
2. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. An WS; Lee SM; Son YK; Kim SE; Kim KH; Han JY; Bae HR; Rha SH; Park Y Nutr Res; 2012 Jul; 32(7):495-502. PubMed ID: 22901557 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers of vascular calcification and mortality in patients with ESRD. Scialla JJ; Kao WH; Crainiceanu C; Sozio SM; Oberai PC; Shafi T; Coresh J; Powe NR; Plantinga LC; Jaar BG; Parekh RS Clin J Am Soc Nephrol; 2014 Apr; 9(4):745-55. PubMed ID: 24458076 [TBL] [Abstract][Full Text] [Related]
4. The circulating calcification inhibitors, fetuin-A and osteoprotegerin, but not matrix Gla protein, are associated with vascular stiffness and calcification in children on dialysis. Shroff RC; Shah V; Hiorns MP; Schoppet M; Hofbauer LC; Hawa G; Schurgers LJ; Singhal A; Merryweather I; Brogan P; Shanahan C; Deanfield J; Rees L Nephrol Dial Transplant; 2008 Oct; 23(10):3263-71. PubMed ID: 18463323 [TBL] [Abstract][Full Text] [Related]
5. The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study. Alshahawey M; El Borolossy R; El Wakeel L; Elsaid T; Sabri NA Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):626-633. PubMed ID: 33594986 [TBL] [Abstract][Full Text] [Related]
6. Serum osteoprotegerin is associated with vascular stiffness and the onset of new cardiovascular events in hemodialysis patients. Lee JE; Kim HJ; Moon SJ; Nam JS; Kim JK; Kim SK; Yun GY; Ha SK; Park HC Korean J Intern Med; 2013 Nov; 28(6):668-77. PubMed ID: 24307842 [TBL] [Abstract][Full Text] [Related]
7. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients. Pateinakis P; Papagianni A; Douma S; Efstratiadis G; Memmos D BMC Nephrol; 2013 Jun; 14():122. PubMed ID: 23758931 [TBL] [Abstract][Full Text] [Related]
8. The balance of fetuin-A and osteoprotegerin is independently associated with diastolic dysfunction in hemodialysis patients. Talib A; Nakagawa N; Saito E; Matsuki M; Kobayashi M; Akasaka K; Hirayama T; Ishida H; Sato N; Hasebe N Hypertens Res; 2012 Apr; 35(4):426-33. PubMed ID: 22129515 [TBL] [Abstract][Full Text] [Related]
9. The importance of fetuin-A in vascular calcification in children with chronic kidney disease. Makulska I; Szczepańska M; Drożdż D; Polak-Jonkisz D; Zwolińska D Adv Clin Exp Med; 2019 Apr; 28(4):499-505. PubMed ID: 30070080 [TBL] [Abstract][Full Text] [Related]
10. Potential Correlation Between Circulating Fetuin-A and Pentraxin-3 With Biochemical Parameters of Calcification in Hemodialysis Patients. Hashemi J; Joshaghani HR; Akaberi A; Hesari Z; Ghanbari R; Mohammadzadeh M; Golshan AR Arch Iran Med; 2017 Dec; 20(12):752-755. PubMed ID: 29664315 [TBL] [Abstract][Full Text] [Related]
11. The ratio of osteoprotegerin to fetuin-a is independently associated with vascular stiffness in hemodialysis patients. Kim HR; Kim SH; Han MJ; Yoon YS; Oh DJ Nephron Clin Pract; 2013; 123(3-4):165-72. PubMed ID: 23921088 [TBL] [Abstract][Full Text] [Related]
12. Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients. Lin HH; Liou HH; Wu MS; Huang CC BMC Nephrol; 2016 Mar; 17():33. PubMed ID: 27007989 [TBL] [Abstract][Full Text] [Related]
13. Vascular calcification is not related to serum fetuin-A and osteopontin levels in hemodialysis patients. Ulutas O; Taskapan MC; Dogan A; Baysal T; Taskapan H Int Urol Nephrol; 2018 Jan; 50(1):137-142. PubMed ID: 29134617 [TBL] [Abstract][Full Text] [Related]
14. Fetuin-A as a risk factor for mortality in hemodialysis patients. Pecovnik Balon B; Knehtl M; Bevc S; Jakopin E; Gorenjak M Wien Klin Wochenschr; 2010 May; 122 Suppl 2():63-7. PubMed ID: 20517675 [TBL] [Abstract][Full Text] [Related]